GSK CEO Thinks Highly of Premiums for New Drug Creation, Key to Attractive Market

Andrew Witty, CEO of GSK(UK), Gives Speech at Global Management Forum, Tokyo At a session of the Global Management Forum held in Tokyo on October 25, Andrew Witty, Chief Executive Officer (CEO) of GlaxoSmithKline (GSK) of the UK, showed his...read more